A PIVOTAL, OPEN-LABEL, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WHO HAVE A RECENT HISTORY OF BLOOD TRANSFUSION

Registry ID

BIVV009-03

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

BIOVERATIV USA INC

Start date

2018-02-16

Completion date

2029-01-29

Last update

2017-12-15

Conditions

• COLD AGGLUTININ DISEASE

Related clinical trials

• A MULTICENTER, PHASE 1B, OPEN LABEL, NONRANDOMIZED, SINGLE DOSE STUDY EVALUATING THE SAFETY, TOLERABILITY AND ACTIVITY OF BIVV020 IN ADULTS WITH COLD AGGLUTININ DISEASE
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WITHOUT A RECENT HISTORY OF BLOOD TRANSFUSION

View on source registry